Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADAP | AMGN | BMY | GILD | VRTX |
| Company | Adaptimmune Ther ADR | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.0400 | 272.14 | 49.16 | 67.09 | 404.00 |
| High | 1.1600 | 274.35 | 49.47 | 67.68 | 406.86 |
| Low | 1.0000 | 271.05 | 48.96 | 67.06 | 403.47 |
| Last | 1.1400 | 274.16 | 49.21 | 67.33 | 405.30 |
| Change | +0.1300 | +2.25 | +0.07 | +0.38 | +5.38 |
| % Change | +12.87% | +0.83% | +0.14% | +0.57% | +1.35% |
| Volume | 787,121 | 1,100,250 | 3,904,554 | 2,294,076 | 391,856 |
| 20-Day Average Volume | 1,340,916 | 2,142,042 | 10,678,729 | 6,183,039 | 942,592 |
| Previous Close | 1.0100 | 271.91 | 49.14 | 66.95 | 399.92 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2596 | 272.02 | 50.57 | 69.35 | 404.19 |
| 20-Day Raw Stochastic | 34.44% | 48.83% | 24.42% | 17.06% | 46.75% |
| 20-Day Relative Strength | 45.31% | 49.42% | 43.21% | 34.11% | 48.17% |
| Weighted Alpha | -43.49 | +11.87 | -25.12 | -20.48 | +17.87 |
| Today's Opinion | 40% Buy | 40% Sell | 88% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 24% Buy | 40% Sell | 88% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 80% Buy | 8% Buy | 24% Sell | 88% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.68% since 04/16/24 | +3.26% since 04/16/24 | +2.13% since 04/16/24 | -0.07% since 04/16/24 | +2.81% since 04/16/24 |
| Low | 0.8721 on 04/18/24 | 260.68 on 04/19/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 1.1600 on 04/23/24 | 274.35 on 04/23/24 | 49.56 on 04/22/24 | 67.68 on 04/23/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -20.83% since 03/22/24 | -0.68% since 03/22/24 | -5.08% since 03/22/24 | -7.37% since 03/22/24 | -2.51% since 03/22/24 |
| Low | 0.8721 on 04/18/24 | 260.68 on 04/19/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 1.6500 on 03/28/24 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +50.00% since 01/23/24 | -11.49% since 01/23/24 | -1.66% since 01/23/24 | -15.38% since 01/23/24 | -7.84% since 01/23/24 |
| Low | 0.6905 on 01/25/24 | 260.68 on 04/19/24 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 2.0500 on 03/08/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +89.91% since 10/23/23 | +0.45% since 10/23/23 | -11.98% since 10/23/23 | -13.28% since 10/23/23 | +10.22% since 10/23/23 |
| Low | 0.4200 on 11/28/23 | 249.70 on 10/31/23 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 341.90 on 11/16/23 |
| High | 2.0500 on 03/08/24 | 329.72 on 02/05/24 | 56.77 on 10/25/23 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,004,155 | 145,845,984 | 99,594,944 | 83,357,904 | 103,362,928 |
| Shares Outstanding, K | 994,213 | 536,376 | 2,026,759 | 1,245,077 | 258,459 |
| Annual Sales | 60,280,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -113,870,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 230,000 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -47,920,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 2.39 | 0.58 | 0.39 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 03/06/24 | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/10/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.42 | 6.52 | 9.93 | 29.34 |